Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04308174
Brief Title: Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer (DEBATE)

First Submitted : March 12, 2020
First Submitted that Met QC Criteria : March 12, 2020
First Posted : March 13, 2020

Last Update Submitted that Met QC Criteria : July 21, 2021
Last Update Posted : July 22, 2021